Sean Hart, PhD (@seanjhart) 's Twitter Profile
Sean Hart, PhD

@seanjhart

Chief Scientific Officer & CEO @LumaCyte | Innovative Scientist and Entrepreneur | Analytical Expert | Biotechnology Professional

ID: 1607753581351804928

linkhttp://www.LumaCyte.com calendar_today27-12-2022 15:01:49

189 Tweet

239 Followers

734 Following

Sean Hart, PhD (@seanjhart) 's Twitter Profile Photo

An 11-year-old born with a genetic form of hearing loss experienced restored hearing thanks to a new #GeneTherapy. This dual adeno-associated viral vector-based therapy could be a game-changer, opening up new therapeutic possibilities. genengnews.com/topics/transla…

Sean Hart, PhD (@seanjhart) 's Twitter Profile Photo

As part of a recent study co-led by HMS scientists, a novel #GeneTherapy was tested, restoring the hearing of five children who were born with a form of genetic #deafness. #GeneTherapy #CGT hms.harvard.edu/news/experimen…

Sean Hart, PhD (@seanjhart) 's Twitter Profile Photo

Presented brand new LumaCyte data BEBPA US Bioassay Conference in Long Beach, CA this past Tuesday. We showed initial data correlating Laser Force Cytology measurements of PBMC with the killing efficiency of CAR T products - a very important step to improve the efficiency of

Presented brand new <a href="/LumaCyte/">LumaCyte</a> data <a href="/BEBPA/">BEBPA</a> US Bioassay Conference in Long Beach, CA this past Tuesday. We showed initial data correlating Laser Force Cytology measurements of PBMC with the killing efficiency of CAR T products - a very important step to improve the efficiency of
Sean Hart, PhD (@seanjhart) 's Twitter Profile Photo

Amazing to work with such talented people - we are excited to continue driving innovation and advanced analytics with ATCC.

Sean Hart, PhD (@seanjhart) 's Twitter Profile Photo

Excited to be attending ISCT in Vancouver and really enjoyed participating in the panel discussion on PAT for cell therapy this morning! Thank you ISCT!

LumaCyte (@lumacyte) 's Twitter Profile Photo

Join the LumaCyte Team at Advanced Therapies Week next week in Dallas, Texas. Discover groundbreaking innovations and network with industry leaders at the premier event for advanced therapies. Don’t miss your chance to explore cutting-edge research, gain insights from the

Join the LumaCyte Team at Advanced Therapies Week next week in Dallas, Texas. Discover groundbreaking innovations and network with industry leaders at the premier event for advanced therapies. Don’t miss your chance to explore cutting-edge research, gain insights from the
Bristol Myers Squibb (@bmsnews) 's Twitter Profile Photo

#MEDIA: The European Commission has approved our #CARTcelltherapy for patients living with relapsed or refractory follicular lymphoma (FL). Read more: bit.ly/3Fwuuar

LumaCyte (@lumacyte) 's Twitter Profile Photo

Beyond Viability: Healthier Cells, Better Therapies. What if cell health wasn’t just viable, but optimal? Discover how advanced technologies are reshaping cell therapy by redefining viability. Dive into the future of healthier, more robust cells: lumacyte.com/applications/c…

Beyond Viability: Healthier Cells, Better Therapies.
What if cell health wasn’t just viable, but optimal? Discover how advanced technologies are reshaping cell therapy by redefining viability. Dive into the future of healthier, more robust cells: lumacyte.com/applications/c…
Katherine Stiles (@_k_stiles) 's Twitter Profile Photo

A paralysed man can stand on his own after receiving an injection of neural stem cells to treat his spinal cord injury. The Japanese man was one of four individuals in a first-of-its-kind trial that used reprogrammed stem cells to treat people who are fully paralysed.

A paralysed man can stand on his own after receiving an injection of neural stem cells to treat his spinal cord injury. The Japanese man was one of four individuals in a first-of-its-kind trial that used reprogrammed stem cells to treat people who are fully paralysed.
Sean Hart, PhD (@seanjhart) 's Twitter Profile Photo

Preparing for CAR T cell therapy: A roadmap for patient selection, bridging therapies, and lymphodepletion. This review highlights the critical steps to optimize outcomes for B-cell malignancies. A must-read for oncology cell therapy! Nature Review #CARTCellTherapy

Sean Hart, PhD (@seanjhart) 's Twitter Profile Photo

Interesting and worrying at the same time… AI draws on existing knowledge and by definition peer review of papers is new work, so how can AI ‘judge’ appropriately?

Sean Hart, PhD (@seanjhart) 's Twitter Profile Photo

A chondrocyte cell experiencing laser optical force in fluid flow measured with Laser Force Cytology (LFC). LFC measures 2 dozen biophysical and biochemical parameters for every cell in real time. It's used for quantitative predictive cellular analytics throughout

Extracellular Matrix News (@extracellmatrix) 's Twitter Profile Photo

New in Cancer Discovery! 👏 Dr. Ruth Scherz-Shouval and colleagues unravel a pathway of CAF-mediated suppression of NK cells in #BreastCancer, opening possible avenues for new biomarkers and strategies for immune-based therapies. #TumorMicroenviromment 🔗 bit.ly/3ZdI9dx